Non-TNFi-biologic class ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ1

46. 悪性関節リウマチ


臨床試験数 : 4,356 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04692493
(ClinicalTrials.gov)
September 22, 202115/12/2020RA-PRO PRAGMATIC TRIALA Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients With Rheumatoid Arthritis: The RA-PRO Pragmatic Trial (RA-PROPR)Rheumatoid ArthritisDrug: targeted synthetic DMARD class;Drug: non-TNFi-biologic classUniversity of Alabama at BirminghamPatient-Centered Outcomes Research InstituteRecruiting18 YearsN/AAll924Phase 3United States